Share
3,464 Posts.
lightbulb Created with Sketch. 956
clock Created with Sketch.
09/02/22
15:38
Share
Originally posted by SteadyEddie
↑
Hi again,
to correct what had posted - yes ResApp is aiming to be accepted as a valid screening test - not diagnostic test.
following on from my post I don't realistically see how ResApp Dx will be able to screen for asymptomatic patients - ( no symptoms, no cough , no shortness of breath - my guess accuracy well below 50%. In symptomatic patients with a cough - accuracy maybe 70-80%. In patients with Covid pneumonia - I'd be hoping for 80-90%+. no word from management how much longer we will have to wait for results.
I did hear that the sleepcheck meeting with FDA went very well and that they are confident of approval in coming months.
In the meantime I see revenues building and giving confidence to shareholders ...
Expand
Yes I heard the FDA meeting on Sleep Check went well too
It's in the last conference call by TK
Have a listen ....
Nothing new here
Just posters having fun